全髋关节置换术对同侧全膝关节置换术中长期随访的影响:一项回顾性队列研究

注册号:

Registration number:

ChiCTR2000035147 

最近更新日期:

Date of Last Refreshed on:

2020-08-02 04:47:49 

注册时间:

Date of Registration:

2020-08-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

全髋关节置换术对同侧全膝关节置换术中长期随访的影响:一项回顾性队列研究

Public title:

Mid-long term results of total knee arthroplasty followed by ipsilateral total hip arthroplasty versus total hip arthroplasty subsequent to ipsilateral total knee arthroplasty: A retrospective cohort study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

全髋关节置换术对同侧全膝关节置换术中长期随访的影响:一项回顾性队列研究

Scientific title:

Mid-long term results of total knee arthroplasty followed by ipsilateral total hip arthroplasty versus total hip arthroplasty subsequent to ipsilateral total knee arthroplasty: A retrospective cohort study

研究课题代号(代码):

Study subject ID:

四川大学华西医院基金(ZYJC18039)

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘尊瀚 

研究负责人:

周宗科 

Applicant:

Zunhan Liu 

Study leader:

Zongke Zhou 

申请注册联系人电话:

Applicant telephone:

+86 13527532254

研究负责人电话:

Study leader's
telephone:

+86 18980601028

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liuzunhan@126.com

研究负责人电子邮件:

Study leader's E-mail:

zhouzongke@scu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国四川省成都市武侯区国学巷37号

研究负责人通讯地址:

中国四川省成都市武侯区国学巷37号

Applicant address:

37 Guoxue lane, Wuhou District, Chengdu, Sichuan, China

Study leader's address:

37 Guoxue lane, Wuhou District, Chengdu, Sichuan, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川大学华西医院

Applicant's institution:

West China Hospital, Sichuan University

研究负责人所在单位:

四川大学华西医院

Affiliation of the Leader:

West China Hospital, Sichuan University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2012-268

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院临床试验与生物医学伦理专委会

Name of the ethic committee:

Special Committee on clinical trials and biomedical ethics of West China Hospital of Sichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2013-01-08 00:00:00

伦理委员会联系人:

左泽锦

Contact Name of the ethic committee:

Zejin Zuo

伦理委员会联系地址:

四川省成都市武侯区国学巷37号四川大学华西医院老八教四楼412室

Contact Address of the ethic committee:

Room 412, Old 8th Teaching Building, West China Hospital, Sichuan University, 37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学附属华西医院

Primary sponsor:

West China Hospital, Sichuan University

研究实施负责(组长)单位地址:

中国四川省成都市武侯区国学巷37号

Primary sponsor's address:

37 Guoxue lane, Wuhou District, Chengdu, Sichuan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

经费或物资来源:

四川大学华西医院基金(ZYJC18039)

Source(s) of funding:

West China Hospital Foundation of Sichuan University(ZYJC18039)

研究疾病:

膝关节骨关节炎/膝关节类风湿性关节炎  

Target disease:

knee osteoarthritis/ knee rheumatoid arthritise

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究的目的是通过比较先行全髋关节置换术再行同侧全膝关节置换术与前行全膝关节置换术再行同侧全髋关节置换术的中长期结果,评估术前THA对随后TKA的影响。  

Objectives of Study:

the objective of this study was to assess the influence of a prior THA on a subsequent TKA by comparing the mid-long term results of TKA followed by ipsilateral THA and THA subsequent to ipsilateral TKA.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

排除标准为髋关节发育不良、髋臼或股骨骨折、强直性脊柱炎、既往下肢骨折、创伤后关节炎、THA或TKA翻修术,以及不完整的临床或影像学记录。此外,为了避免与先前TJA相关的偏倚,同侧THA和TKA之间的间隔时间小于6个月的患者以及在随后的手术中功能评分低于70分的患者也被排除在外。

Exclusion criteria:

Hip dysplasia, acetabulum or femoral fracture, ankylosing spondylitis, prior lower extremity fracture, posttraumatic arthritis, revision THA or TKA, and incomplete clinical or radiographic records. Additionally, to avoid bias in related to prior TJA, patients with interval time between ipsilateral THA and TKA shorter than 6 months and patients who underwent prior TJA with a functional score at the time of subsequent surgery less than 70 points were also excluded.

研究实施时间:

Study execute time:

From 2020-08-01 00:00:00 To 2020-09-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-08-01 00:00:00 To 2020-08-20 00:00:00

干预措施:

Interventions:

组别:

Two cohorts

样本量:

83

Group:

Two cohorts

Sample size:

干预措施:

同侧全髋关节置换术vs全膝关节置换术

干预措施代码:

Intervention:

ipsilateral total hip arthroplasty versus total knee arthroplasty

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

华西医院 

单位级别:

三级甲等医院 

Institution
hospital:

West China Hospital

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

术后并发症

指标类型:

主要指标

Outcome:

postoperative complications

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

翻修

指标类型:

主要指标

Outcome:

revision

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后活动功能

指标类型:

主要指标

Outcome:

postoperative functional outcome

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后下肢力线的改变

指标类型:

主要指标

Outcome:

postoperative alignment alteration

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

全髋关节置换术与全膝关节置换术的间隔时间

指标类型:

次要指标

Outcome:

interval between total hip arthroplasty and total knee arthroplasty

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术前髋关节活动评分

指标类型:

次要指标

Outcome:

Preoperative harris hip score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术前膝关节功能评分

指标类型:

次要指标

Outcome:

preoperative knee functional score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

Nil

组织:

Sample Name:

Nil

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

该研究是一个队列研究,不涉及随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

this study is a cohort study, non randomized.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

不适用

Blinding:

N/A

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

网络平台

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Internet database

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-08-02 04:43:13